11-68903761-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_181514.2(MRPL21):āc.50G>Cā(p.Cys17Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,613,080 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_181514.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRPL21 | NM_181514.2 | c.50G>C | p.Cys17Ser | missense_variant | 1/7 | ENST00000362034.7 | NP_852615.1 | |
MRPL21 | XM_005273823.5 | c.50G>C | p.Cys17Ser | missense_variant | 1/6 | XP_005273880.1 | ||
MRPL21 | NM_181515.2 | c.-219G>C | 5_prime_UTR_variant | 1/7 | NP_852616.1 | |||
MRPL21 | XR_247190.5 | n.72G>C | non_coding_transcript_exon_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRPL21 | ENST00000362034.7 | c.50G>C | p.Cys17Ser | missense_variant | 1/7 | 1 | NM_181514.2 | ENSP00000354580.2 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152276Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248934Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135192
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460804Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 726734
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152276Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74404
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2024 | The c.50G>C (p.C17S) alteration is located in exon 1 (coding exon 1) of the MRPL21 gene. This alteration results from a G to C substitution at nucleotide position 50, causing the cysteine (C) at amino acid position 17 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at